American Origin Unverified This profile is unclaimed and has not been independently reviewed. Claim & get verified

VYNE Therapeutics Inc. (VYNE)

$28.56 +12.22% NASDAQ: VYNE · 15-min delayed

BRIDGEWATER, New Jersey
Public · NASDAQ: VYNE
10 employees

Visit website Follow

$339.9KMarket cap

$570.0KRevenue · FY2025

-$26.5MNet income

10Employees

VYNENASDAQ

2018IPO

About VYNE Therapeutics Inc.

VYNE Therapeutics Inc is a biopharmaceutical company focused on developing proprietary and differentiated therapies for the treatment of immuno-inflammatory conditions. The company is also in the pre-clinical stages of research, develop and commercialize products containing small molecule bromodomain and extra-terminal domain (BET) inhibitors for the treatment of any disease, disorder or condition in human. Its products include AMZEEQ, ZILXI, and FCD105.

This profile is unclaimed. An authorized representative can claim it free to control the page and activate the embeddable Verified badge.

Company facts

Type: Public · NASDAQ: VYNE
Employees: 10
IPO date: Jan 25, 2018
Headquarters: 685 ROUTE 202/206 N., SUITE 301
BRIDGEWATER, New Jersey 08807
Phone: 800-775-7936
Industry: Pharmaceuticals
Website: Visit site

Registry IDs

Ticker: VYNE Nasdaq
SEC CIK: 1566044
EIN: 453757789
SIC: 2834 PHARMACEUTICAL PREPARATIONS

Explore our data studies: the biggest company in every US state · all rankings & reports.

Embed this company’s badge

Show VYNE Therapeutics Inc.’s American-company profile badge on a website — copy this HTML:

<a href="https://americancompanies.com/company/vyne-therapeutics-inc/"><img src="https://americancompanies.com/badge/vyne-therapeutics-inc.svg" alt="VYNE Therapeutics Inc. — American company profile on americancompanies.com" width="220"></a>

Is this your company?

This profile is unclaimed — any authorized owner can claim it free, control the page, and activate the embeddable Verified badge for their own website.

Claim this profile — free

Track American companies

Create a free account to follow VYNE Therapeutics Inc. and get an email when it moves sharply — real market data, 15-minute delayed.

Create free account

Reported figures

Financial summary

Revenue FY2025: $570.0K
Net income: -$26.5M
Total assets: $30.2M
Market cap: $339.9K

Source: SEC EDGAR · updated Jun 7, 2026

NASDAQ: VYNE

$28.56 +12.22%

15-minute delayed · data by Polygon.io

Past year · hover for prices

$15.80 $46.17

52-week range

Market cap: $339.9K
Shares outstanding: 11.9K
Open: —
Day range: –
Prev close: —
Volume: —
IPO date: Jan 25, 2018

VYNE Therapeutics Inc. (VYNE) Stock Price

Reported a net loss of $26.5M in FY2025.
Trading 38% below its 52-week high.

Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.

No reviews yet. Be the first to review VYNE Therapeutics Inc..

Write a review

Newsroom

News about VYNE Therapeutics Inc.

SHAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger--VYNE, MASI, IBCP, and HCBN Benzinga · 2026-04-01 · negative Halper Sadeh LLC Encourages FOLD, VYNE, HTBK, FMNB Shareholders to Contact the Firm to Discuss Their Rights GlobeNewswire Inc. · 2025-12-20 · negative VYNE Therapeutics and Yarrow Bioscience Announce Merger Agreement GlobeNewswire Inc. · 2025-12-17 · neutral Vitiligo Clinical Trial Pipeline Accelerates as 18+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight GlobeNewswire Inc. · 2025-08-14 · positive VYNE Therapeutics to Participate in Leerink Partners Therapeutics Forum GlobeNewswire Inc. · 2024-06-26 Analyst Scoreboard: 4 Ratings For VYNE Therapeutics Benzinga · 2024-06-14

News & sentiment via Polygon.io

FAQ

VYNE Therapeutics Inc.: frequently asked questions

Is VYNE Therapeutics Inc. an American company?

VYNE Therapeutics Inc. is a US-based company headquartered in Bridgewater, New Jersey, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.

Where is VYNE Therapeutics Inc. headquartered?

VYNE Therapeutics Inc. is headquartered in Bridgewater, New Jersey, United States.

Is VYNE Therapeutics Inc. publicly traded?

Yes — VYNE Therapeutics Inc. is a publicly traded company. Its stock trades under the ticker symbol VYNE on the NASDAQ.

What does VYNE Therapeutics Inc. do?

VYNE Therapeutics Inc. is an American Pharmaceuticals company in the Health & Beauty sector.

Explore